Unity Biotechnology, Inc. (UBX) symbol metrics page

Unity Biotechnology Inc. (UBX) NASDAQ

$1.47 (0.02) (-1.34%)

Market Cap: $25.01M

As of 04/24/24 04:00 PM EDT. Market closed.

(UBX)

Unity Biotechnology Inc. (UBX)
NASDAQ

$1.47
(0.02) (-1.34%)

Market Cap: $25.01M

As of 04/24/24 04:00 PM EDT. Market closed.

Add to Portfolio

unity biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. unity's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. more information is available at ... read more

COMPANY PROFILE

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology

CEO

Anirvan Ghosh

Full Time Employees

46

CEO Compensation (Base)

$500,000

CEO Compensation (Total)

$2.73M

URL

unitybiotechnology.com

Address

3280 Bayshore Blvd, California, Brisbane, 94005-1028.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology

CEO

Anirvan Ghosh

Full Time Employees

46

CEO Compensation (Base)

$500,000

CEO Compensation (Total)

$2.73M

URL

unitybiotechnology.com

Address

3280 Bayshore Blvd, California, Brisbane, 94005-1028.

PRICE CHART FOR UNITY BIOTECHNOLOGY INC

1w

1m

3m

6m

YTD

1y

5y

MAX

From: To:

NEWS

INSIDEARBITRAGE ARTICLES

KEY STATS

Open

$1.48

Previous Close

$1.49

Days Range

$1.46 - $1.51

52 week range

$1.47 - $3.82

Volume

82,056

Avg. Volume (30 days)

58,007

Market Cap

$25.01M

Dividend Yield

-

P/E

-

Shares Outstanding

16,786,647

Open

$1.48

Previous Close

$1.49

Days Range

$1.46 - $1.51

52 week range

$1.47 - $3.82

Volume

82,056

Avg. Volume (30 days)

58,007

Market Cap

$25.01M

Dividend Yield

-

P/E

-

Shares Outstanding

16,786,647

FINANCIAL STATEMENTS FOR UNITY BIOTECHNOLOGY INC

LOADING...

Open in:

Open in:

INSIDER TRANSACTIONS FOR UNITY BIOTECHNOLOGY INC

Owner	Relationship	Date	Transaction	Cost	# Shares	Value($)	Total Shares	Form 4
Ghosh Anirvan	Chief Executive Officer	Feb 02, 2024	Sale	$1.71	680	1,163	78,746	Feb 05, 2024, 04:05 PM
Ghosh Anirvan	Chief Executive Officer	Jan 30, 2024	Sale	$1.71	1,183	2,023	79,426	Jan 31, 2024, 04:05 PM
Ghosh Anirvan	Chief Executive Officer	Nov 02, 2023	Sale	$1.83	589	1,078	80,609	Nov 03, 2023, 04:05 PM
Ghosh Anirvan	Chief Executive Officer	Oct 30, 2023	Sale	$1.90	1,024	1,946	81,198	Oct 31, 2023, 04:05 PM
Ghosh Anirvan	Chief Executive Officer	Sep 14, 2023	Sale	$2.47	1,246	3,078	82,222	Sep 15, 2023, 04:08 PM
Ghosh Anirvan	Chief Executive Officer	Aug 02, 2023	Sale	$2.94	581	1,708	83,468	Aug 03, 2023, 04:13 PM
Ghosh Anirvan	Chief Executive Officer	Jul 31, 2023	Sale	$2.86	1,020	2,917	84,049	Aug 01, 2023, 04:05 PM
Ghosh Anirvan	Chief Executive Officer	Jun 26, 2023	Sale	$3.20	1,177	3,766	85,069	Jun 27, 2023, 05:10 PM
Ghosh Anirvan	Chief Executive Officer	Jun 14, 2023	Sale	$3.39	1,212	4,109	86,246	Jun 15, 2023, 05:58 PM
Ghosh Anirvan	Chief Executive Officer	May 02, 2023	Sale	$2.17	588	1,276	87,458	May 03, 2023, 05:26 PM
Ghosh Anirvan	Chief Executive Officer	May 01, 2023	Sale	$2.15	1,020	2,193	88	May 02, 2023, 04:32 PM
Ghosh Anirvan	Chief Executive Officer	Mar 31, 2023	Sale	$1.70	1,959	3,330	89,066	Apr 03, 2023, 04:55 PM
Dananberg Jamie	Chief Medical Officer	Mar 31, 2023	Sale	$1.70	420	714	62,817	Apr 03, 2023, 04:51 PM
Dananberg Jamie	Chief Medical Officer	Mar 14, 2023	Sale	$4.00	1,005	4,020	63,237	Mar 15, 2023, 05:02 PM
Ghosh Anirvan	Chief Executive Officer	Mar 14, 2023	Sale	$4.00	1,210	4,840	91,025	Mar 15, 2023, 04:51 PM
Dananberg Jamie	Chief Medical Officer	Feb 02, 2023	Sale	$4.84	863	4,177	64,242	Feb 03, 2023, 04:33 PM
Ghosh Anirvan	Chief Executive Officer	Feb 02, 2023	Sale	$4.84	2,573	12,453	92,235	Feb 03, 2023, 04:27 PM
Ghosh Anirvan	Chief Executive Officer	Jan 30, 2023	Sale	$4.45	1,140	5,073	94,808	Jan 31, 2023, 04:48 PM
Ghosh Anirvan	Chief Executive Officer	Dec 14, 2022	Sale	$2.85	1,274	3,631	95,948	Dec 15, 2022, 04:48 PM
Dananberg Jamie	Chief Medical Officer	Dec 14, 2022	Sale	$2.85	1,016	2,896	65,105	Dec 15, 2022, 04:44 PM
Sullivan Lynne Marie	CFO & Head of Corp. Dev.	May 15, 2022	Option Exercise	$6.89	925	6,373	33,009	Nov 21, 2022, 05:26 PM
Ghosh Anirvan	Chief Executive Officer	Nov 03, 2022	Sale	$2.40	1,099	2,638	97,222	Nov 04, 2022, 04:49 PM
Ghosh Anirvan	Chief Executive Officer	Sep 14, 2022	Sale	$0.48	13,706	6,579	983,210	Sep 15, 2022, 04:11 PM
Dananberg Jamie	Chief Medical Officer	Sep 14, 2022	Sale	$0.48	10,923	5,243	661,213	Sep 15, 2022, 04:10 PM
Ghosh Anirvan	Chief Executive Officer	Aug 01, 2022	Sale	$0.67	10,446	6,999	996,916	Aug 02, 2022, 04:12 PM
Dananberg Jamie	Chief Medical Officer	Jun 27, 2022	Sale	$0.59	4,398	2,595	672,136	Jun 28, 2022, 06:11 PM
Ghosh Anirvan	Chief Executive Officer	Jun 27, 2022	Sale	$0.59	12,149	7,168	1,007,362	Jun 28, 2022, 06:07 PM
Dananberg Jamie	Chief Medical Officer	Jun 21, 2022	Sale	$0.62	3,697	2,292	676,534	Jun 22, 2022, 04:49 PM
Ghosh Anirvan	Chief Executive Officer	Jun 14, 2022	Option Exercise	$0.63	12,683	7,990	1,019,511	Jun 15, 2022, 04:36 PM
Dananberg Jamie	Chief Medical Officer	Jun 14, 2022	Option Exercise	$0.63	10,530	6,634	680,231	Jun 15, 2022, 04:34 PM
Ghosh Anirvan	Chief Executive Officer	May 02, 2022	Option Exercise	$0.88	7,729	6,802	1,032,194	May 03, 2022, 05:18 PM
Ghosh Anirvan	Chief Executive Officer	Mar 31, 2022	Option Exercise	$1.14	14,472	16,498	1,039,923	Apr 01, 2022, 04:24 PM
Dananberg Jamie	Chief Medical Officer	Mar 31, 2022	Option Exercise	$1.14	4,188	4,774	690,761	Apr 01, 2022, 04:24 PM
Ghosh Anirvan	Chief Executive Officer	Mar 14, 2022	Option Exercise	$0.88	9,272	8,159	1,054,395	Mar 15, 2022, 04:54 PM
Dananberg Jamie	Chief Medical Officer	Mar 14, 2022	Option Exercise	$0.88	10,581	9,311	694,949	Mar 15, 2022, 04:53 PM
Dananberg Jamie	Chief Medical Officer	Dec 14, 2021	Option Exercise	$1.63	10,614	17,301	659,697	Dec 15, 2021, 04:26 PM
Dananberg Jamie	Chief Medical Officer	Mar 30, 2021	Option Exercise	$2.95	40,564	119,664	670,311	Oct 01, 2021, 09:57 PM
Dananberg Jamie	Chief Medical Officer	Jun 21, 2021	Option Exercise	$4.18	3,515	14,693	685,875	Jun 23, 2021, 05:03 PM
Dananberg Jamie	Chief Medical Officer	Mar 30, 2021	Option Exercise	$5.73	2,829	16,210	689,390	Apr 01, 2021, 05:13 PM
David Nathaniel E	President	Dec 16, 2020	Sale	$5.24	1,700,000	8,908,000	624,703	Dec 18, 2020, 05:14 PM
Goeltz II Robert C.	Chief Financial Officer	Jun 22, 2020	Option Exercise	$9.67	2,483	24,011	161,027	Jun 24, 2020, 05:03 PM
David Nathaniel E	President	Jun 22, 2020	Option Exercise	$9.67	2,483	24,011	2,324,703	Jun 24, 2020, 05:00 PM
Marquess Dan	Chief Scientific Officer	Jun 22, 2020	Option Exercise	$9.67	2,483	24,011	380,690	Jun 24, 2020, 04:59 PM
Dananberg Jamie	Chief Medical Officer	Jun 22, 2020	Option Exercise	$9.67	2,483	24,011	452,219	Jun 24, 2020, 04:59 PM
Tompkins Tamara	See Remarks	Jun 22, 2020	Option Exercise	$9.67	2,483	24,011	42,847	Jun 24, 2020, 04:58 PM
Leonard Keith R	Director	Jun 22, 2020	Option Exercise	$9.67	4,711	45,555	89,546	Jun 24, 2020, 04:58 PM
David Nathaniel E	President	Jun 05, 2020	Buy	$8.90	3,200	28,478	2,327,186	Jun 09, 2020, 04:44 PM
Goeltz II Robert C.	Chief Financial Officer	Feb 24, 2020	Option Exercise	$3.43	10,000	34,300	134,404	Feb 26, 2020, 05:48 PM
Leonard Keith R	Chief Executive Officer	Jun 19, 2019	Option Exercise	$3.40	20,000	68,000	170,782	Jun 19, 2019, 09:14 PM
Goeltz II Robert C.	Chief Financial Officer	Oct 10, 2018	Option Exercise	$3.43	5,000	17,150	101,348	Oct 12, 2018, 05:36 PM

Load More Insider Transactions

Buy Sale Option Exercise

Owner	Relationship	Date	Value($)
Ghosh Anirvan	Chief Executive Officer	02/02/2024	1,163
Ghosh Anirvan	Chief Executive Officer	01/30/2024	2,023
Ghosh Anirvan	Chief Executive Officer	11/02/2023	1,078
Ghosh Anirvan	Chief Executive Officer	10/30/2023	1,946
Ghosh Anirvan	Chief Executive Officer	09/14/2023	3,078
Ghosh Anirvan	Chief Executive Officer	08/02/2023	1,708
Ghosh Anirvan	Chief Executive Officer	07/31/2023	2,917
Ghosh Anirvan	Chief Executive Officer	06/26/2023	3,766
Ghosh Anirvan	Chief Executive Officer	06/14/2023	4,109
Ghosh Anirvan	Chief Executive Officer	05/02/2023	1,276
Ghosh Anirvan	Chief Executive Officer	05/01/2023	2,193
Ghosh Anirvan	Chief Executive Officer	03/31/2023	3,330
Dananberg Jamie	Chief Medical Officer	03/31/2023	714
Dananberg Jamie	Chief Medical Officer	03/14/2023	4,020
Ghosh Anirvan	Chief Executive Officer	03/14/2023	4,840
Dananberg Jamie	Chief Medical Officer	02/02/2023	4,177
Ghosh Anirvan	Chief Executive Officer	02/02/2023	12,453
Ghosh Anirvan	Chief Executive Officer	01/30/2023	5,073
Ghosh Anirvan	Chief Executive Officer	12/14/2022	3,631
Dananberg Jamie	Chief Medical Officer	12/14/2022	2,896
Sullivan Lynne Marie	CFO & Head of Corp. Dev.	05/15/2022	6,373
Ghosh Anirvan	Chief Executive Officer	11/03/2022	2,638
Ghosh Anirvan	Chief Executive Officer	09/14/2022	6,579
Dananberg Jamie	Chief Medical Officer	09/14/2022	5,243
Ghosh Anirvan	Chief Executive Officer	08/01/2022	6,999
Dananberg Jamie	Chief Medical Officer	06/27/2022	2,595
Ghosh Anirvan	Chief Executive Officer	06/27/2022	7,168
Dananberg Jamie	Chief Medical Officer	06/21/2022	2,292
Ghosh Anirvan	Chief Executive Officer	06/14/2022	7,990
Dananberg Jamie	Chief Medical Officer	06/14/2022	6,634
Ghosh Anirvan	Chief Executive Officer	05/02/2022	6,802
Ghosh Anirvan	Chief Executive Officer	03/31/2022	16,498
Dananberg Jamie	Chief Medical Officer	03/31/2022	4,774
Ghosh Anirvan	Chief Executive Officer	03/14/2022	8,159
Dananberg Jamie	Chief Medical Officer	03/14/2022	9,311
Dananberg Jamie	Chief Medical Officer	12/14/2021	17,301
Dananberg Jamie	Chief Medical Officer	03/30/2021	119,664
Dananberg Jamie	Chief Medical Officer	06/21/2021	14,693
Dananberg Jamie	Chief Medical Officer	03/30/2021	16,210
David Nathaniel E	President	12/16/2020	8,908,000
Goeltz II Robert C.	Chief Financial Officer	06/22/2020	24,011
David Nathaniel E	President	06/22/2020	24,011
Marquess Dan	Chief Scientific Officer	06/22/2020	24,011
Dananberg Jamie	Chief Medical Officer	06/22/2020	24,011
Tompkins Tamara	See Remarks	06/22/2020	24,011
Leonard Keith R	Director	06/22/2020	45,555
David Nathaniel E	President	06/05/2020	28,478
Goeltz II Robert C.	Chief Financial Officer	02/24/2020	34,300
Leonard Keith R	Chief Executive Officer	06/19/2019	68,000
Goeltz II Robert C.	Chief Financial Officer	10/10/2018	17,150

Load More Insider Transactions

FUNDS WITH A POSITION IN UNITY BIOTECHNOLOGY INC

Fund	# Shares Owned	% of Portfolio	% Change	Investing Style
GEODE CAPITAL MANAGEMENT, LLC	131,782	0.00003%	No change	Other
BLACKROCK INC.	113,081	0.00001%	-0.33%	Other
UBS OCONNOR LLC	92,700	0.01%	-48.24%	Value
RENAISSANCE TECHNOLOGIES LLC	38,171	0.00011%	-0.52%	Other

CHANGE IN SHARES OUTSTANDING FOR UNITY BIOTECHNOLOGY INC

STOCK BUYBACKS FOR UNITY BIOTECHNOLOGY INC

Period of Report

Previous Period

% Change in Shares

10-K/10-Q Filings

Quarter

12/31/2023

09/30/2023

7.92%

1Q

12/31/2023

06/30/2023

9.21%

2Q

12/31/2023

03/31/2023

10.07%

3Q

12/31/2023

09/30/2022

56.42%

5Q

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period

% Change in Shares

Quarter

09/30/2023

7.92%

1Q

06/30/2023

9.21%

2Q

03/31/2023

10.07%

3Q

09/30/2022

56.42%

5Q

BUYBACK ANNOUNCEMENT(S) FOR UNITY BIOTECHNOLOGY INC

Active Completed

LOADING...